IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Investor AB

Q2 2026 Holdings

Filed 2026-08-14 | 7 holdings | $14.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Astrazeneca PLC(AZN)ORDG0593M107$9.8B51,587,81067.9%
Nasdaq Inc(NDAQ)COM631103108$4.6B58,439,20832.0%
Mediwound LTD(MDWD)SHS NEWM68830112$12.8M872,0930.1%
Cellebrite DI LTD(CLBT)ORDINARY SHARESM2197Q107$1.1M75,0000.0%
Micron Technology Inc(MU)COM595112103$542.5K4700.0%
Verizon Communications Inc(VZ)COM92343V104$478.4K11,3000.0%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$211.7K3,7000.0%